Sands Capital Ventures LLC Has $14.65 Million Stake in UiPath Inc. (NYSE:PATH)

Sands Capital Ventures LLC trimmed its stake in UiPath Inc. (NYSE:PATH) by 49.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,155,246 shares of the healthcare company’s stock after selling 1,148,206 shares during the period. UiPath makes up approximately 4.9% of Sands Capital Ventures LLC’s portfolio, making the stock its 4th biggest holding. Sands Capital Ventures LLC owned approximately 0.20% of UiPath worth $14,649,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the stock. Vanguard Group Inc. boosted its stake in UiPath by 5.6% in the first quarter. Vanguard Group Inc. now owns 40,217,936 shares of the healthcare company’s stock worth $911,741,000 after buying an additional 2,133,078 shares in the last quarter. Pacer Advisors Inc. purchased a new stake in shares of UiPath in the 2nd quarter valued at $69,180,000. Dimensional Fund Advisors LP grew its holdings in shares of UiPath by 37.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 2,783,571 shares of the healthcare company’s stock valued at $35,296,000 after purchasing an additional 754,519 shares during the last quarter. Bank of New York Mellon Corp raised its position in UiPath by 20.8% in the 2nd quarter. Bank of New York Mellon Corp now owns 2,552,921 shares of the healthcare company’s stock worth $32,371,000 after purchasing an additional 439,344 shares during the period. Finally, Artisan Partners Limited Partnership bought a new stake in UiPath in the fourth quarter worth $48,267,000. 62.50% of the stock is currently owned by institutional investors.

Insider Activity

In related news, CFO Ashim Gupta sold 47,671 shares of the business’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $12.07, for a total value of $575,388.97. Following the completion of the transaction, the chief financial officer now directly owns 849,917 shares in the company, valued at approximately $10,258,498.19. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 22.37% of the company’s stock.

UiPath Price Performance

Shares of NYSE PATH opened at $12.49 on Friday. UiPath Inc. has a 1 year low of $10.37 and a 1 year high of $27.87. The firm has a 50-day moving average of $12.13 and a 200 day moving average of $16.01. The stock has a market cap of $7.15 billion, a P/E ratio of -78.06 and a beta of 0.87.

UiPath (NYSE:PATH) last posted its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.01. The company had revenue of $316.00 million during the quarter, compared to analyst estimates of $303.69 million. UiPath had a negative return on equity of 3.98% and a negative net margin of 8.13%. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same quarter last year, the company earned ($0.09) EPS. Research analysts expect that UiPath Inc. will post -0.23 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

PATH has been the topic of several analyst reports. DA Davidson lifted their price objective on UiPath from $13.00 to $15.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of UiPath in a research note on Friday, September 6th. Bank of America boosted their price objective on UiPath from $16.00 to $18.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. Barclays lifted their target price on shares of UiPath from $14.00 to $15.00 and gave the stock an “equal weight” rating in a research note on Friday, September 6th. Finally, KeyCorp reissued a “sector weight” rating on shares of UiPath in a report on Thursday, May 30th. Sixteen investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $17.71.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.